Phone: (866) 473-8547  |  Email: info@pharmacaribe.com

Salt Therapy Becoming Mainstream

Posted in Company News | 09.19.14

Even those without respiratory difficulties are finding the healing properties of salt. A recent story by ABC News talks about how 'salt spas' are becoming the newest trend in luxury pampering. Read more about this new trend at ABCNews.com. The health conscious are embracing the latest trend in pampering -- salt spas.  

PharmaCaribe to Attend NACFC October 8-10th

Posted in Company News | 09.19.14

PharmaCaribe will be attending this year's upcoming North American Cystic Fibrosis Conference in Phoenix, Arizona. We will be participating as an exhibitor to showcase our unique pH-balanced PulmoSal 7% pH+ Sodium Chloride Solution. If you are attending, stop by our booth for more information!

Inhaling hypertonic saline decreases hospital admissions…

Posted in Company News | 09.19.14

A recent study published in May indicates that children treated with inhaled hypertonic saline may be less likely to require hospital admission for bronchiolitis when compared with regular saline treatment. Read more about this new study at ScienceDaily.com. A team of researchers, led by physicians from Children's Hospital Los Angeles, have found that infants with bronchiolitis who were treated with inhaled hypertonic saline in the emergency department (ED) were less likely to require admission to the hospital compared to infants treated with normal saline.  

PharmaCaribe Launches New Website!

Posted in Company News | 09.19.14

A patient-focused design with patient-friendly content was the goal of PharmaCaribe's new website launch. Just recently debuted online, the new PharmaCaribe.com includes all the information you need about our line of hypertonic saline solutions, plus a user-focused blog and Frequently Asked Questions area that can help you navigate the range of cystic fibrosis treatment options. Look around, and as always, contact us with any questions about how to get our products.

PharmaCaribe Introduces Next Generation Buffered 7% Saline Solution for Inhalation

Posted in Press Releases | 10.10.13

Punta Gorda, FL – PharmaCaribe’s PulmoSal™ 7% (pH+)™ (sterile sodium chloride inhalation solution 7%, pH 7.4) received FDA Clearance for commercialization on March 13, 2013 and will be available by prescription from Cystic Fibrosis Services, A Walgreens Alliance Pharmacy on December 1, 2013, and from other pharmacies shortly thereafter. PulmoSal™ 7% (pH+)™ is the first and only FDA-cleared buffered formulation of 7% saline solution for inhalation.